Manuel Monreal

Laurent Bertoletti2
Javier Trujillo-Santos2
Alessandra Bura-Riviere2
2Laurent Bertoletti
2Javier Trujillo-Santos
2Alessandra Bura-Riviere
2Pierpaolo Di Micco
1David Zeltser
Learn More
This work at ®rst look discusses the in¯uence of the tool path strategy on the cycle time of high-speed milling operations. Experiments and predictions were focused on pocketing operations with a zigzag tool path, quantifying the signi®cant discrepancy between the programmed feed rate and the actual average feed rate. A mechanistic approach for cycle time(More)
OBJECTIVE To obtain a realistic overview of management and clinical outcomes of patients with venous thromboembolism (VTE) in Spain on the basis of data from a national multicenter registry. METHODS A prospective registry was initiated in Spain in March 2001. Data were collected from patients with objectively confirmed deep vein thrombosis (DVT) and/or(More)
  • Angeles Blanco-Molina, Iolanda Enea, Telma Gadelha, Antonella Tufano, Alessandra Bura-Riviere, Pierpaolo Di Micco +4 others
  • 2014
In patients with venous thromboembolism (VTE), the outcome during the course of anticoagulant therapy may differ according to the patient's sex. We used the RIETE (Registro Informatizado Enfermedad TromboEmbólica) database to compare the rate of VTE recurrences, major bleeding, and mortality due to these events according to sex.As of August 2013, 47,499(More)
  • Laurent Bertoletti, Sara Quenet, Silvy Laporte, Joan Carles Sahuquillo, Francisco Conget, José María Pedrajas +4 others
  • 2013
BACKGROUND Patients with chronic obstructive pulmonary disease (COPD) have a modified clinical presentation of venous thromboembolism (VTE) but also a worse prognosis than non-COPD patients with VTE. As it may induce therapeutic modifications, we evaluated the influence of the initial VTE presentation on the 3-month outcomes in COPD patients. METHODS COPD(More)
  • Dominique Farge, Javier Trujillo-Santos, Philippe Debourdeau, Alessandra Bura-Riviere, Eva Maria Rodriguez-Beltrán, Jose Antonio Nieto +6 others
  • 2015
In cancer patients treated for venous thromboembolism (VTE), including deep-vein thrombosis (DVT) and pulmonary embolism (PE), analyzing mortality associated with recurrent VTE or major bleeding is needed to determine the optimal duration of anticoagulation.This was a cohort study using the Registro Informatizado de Enfermedad TromboEmbólica (RIETE)(More)
  • Isabelle Mahé, Raluca Sterpu, Laurent Bertoletti, Luciano López-Jiménez, Meritxell Mellado Joan, Javier Trujillo-Santos +5 others
  • 2015
Current guidelines of antithrombotic therapy suggest early initiation of vitamin K antagonists (VKA) in non-cancer patients with venous thromboembolism (VTE), and long-term therapy with low-molecular weight heparin (LMWH) for those with cancer. We used data from RIETE (international registry of patients with VTE) to report the use of long-term anticoagulant(More)
  • Giancarlo Agnelli, Anselm K. Gitt, Rupert Bauersachs, Eva-Maria Fronk, Petra Laeis, Patrick Mismetti +4 others
  • 2015
BACKGROUND Venous thromboembolism (VTE) is a major health problem, with over one million events every year in Europe. However, there is a paucity of data on the current management in real life, including factors influencing treatment pathways, patient satisfaction, quality of life (QoL), and utilization of health care resources and the corresponding costs.(More)
The Registro Informatizado de Enfermedad TromboEmbólica (RIETE Registry) is an ongoing, international, prospective registry of consecutive patients with acute venous thromboembolism (VTE) designed to gather and analyze data on treatment patterns and outcomes in patients with acute VTE. It started in Spain in 2001, and 6 years later the database was(More)
  • 1